Informing Maternal Immunization Trials: An Observational Study to Assess Background Rates of Maternal, Pregnancy, and Neonatal/Infant Outcomes
Overall, the proportions of the outcomes assessed were generally consistent with previously published literature of pregnant individuals and their infants in the United States (US). The study provides background rates of important maternal, pregnancy and neonatal/infant outcomes in a US population that may inform vaccine clinical trials and vaccine safety studies in pregnant individuals.
Authors
- Antonella N. Tullio (ORCID: https://orcid.org/0000-0002-6623-6214)
- Wenji Pu (ORCID: https://orcid.org/0009-0009-5259-8183)
- Ousseny Zerbo (ORCID: https://orcid.org/0000-0002-8380-6215)
- Amber Hsiao (ORCID: https://orcid.org/0000-0003-2295-0886)
- Nicola P. Klein (ORCID: https://orcid.org/0000-0003-1777-4814)
- Julius Timbol
- John Hansen (ORCID: https://orcid.org/0000-0001-7891-2673)
- Se Li (ORCID: https://orcid.org/0000-0003-3255-7877)
- Ned Lewis
Institutions
- Kaiser Permanente Oakland Medical Center (US)
- GlaxoSmithKline (United States) (US)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/inf.0000000000004639
- Citations
- 1
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 2.06